Level Four Financial’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CKPT
JSMC
SAG
EL
Level Four Financial's CKPT Position: Q3 2021 in Review
Level Four Financial held its Checkpoint Therapeutics (CKPT) position steady in Q3 2021 at 1,000 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #293.
Level Four Financial first reported a position in CKPT in Q1 2021 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.
- Level Four Financial held 1,000 shares of Checkpoint Therapeutics worth $33K as of Q3 2021.
- Level Four Financial left its Checkpoint Therapeutics share count unchanged in Q3 2021.
- Checkpoint Therapeutics made up 0.01% of Level Four Financial's portfolio in Q3 2021, its #293 holding.
- Level Four Financial first reported a position in Checkpoint Therapeutics in Q1 2021 and has held it in 3 quarters since.
- 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.
Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.